_in_Mizushima,_Japan_256_384.jpg)
News | February 29, 2024
Asahi Kasei offers pharmaceutical excipient Ceolus with nitrite concentration of 0.1 ppm or less
Contributing to lower risk of potentially carcinogenic nitrosamine impurities in pharmaceuticals
Contributing to lower risk of potentially carcinogenic nitrosamine impurities in pharmaceuticals
The acquisition of Healint aligns with Aptar Digital Health’s strategy to broaden its portfolio in neurology and strengthen its global footprint for digital health deployment
These digital avenues have not only revolutionized patient care but also opened up new opportunities for HCPs to build thought leadership in their respective fields
Commercialization of rPEG lipids designed to improve immunogenicity profile for nucleic acid delivery
The company is strongly committed to enhancing customer satisfaction and catering to the discerning needs of renowned pharmaceutical companies
The agreement is effective from January 1, 2024 and commercialisation commenced on February 1, 2024
Ayush is expanding beyond wellness to therapeutic wellness
The company will be managing orders and warehouse operations for Little's, Lacto-calamine, Tri-activ, I-feel, Ourdaily, and Sloan's through the Unicommerce platform
For 9 months period ended December 2023, the company’s PAT up 16% to Rs 330 crores (before exceptional items)
Glenmark Life Sciences will manufacture API in the therapeutic area of urinary anti-spasmodic, to supply to the global innovator
Subscribe To Our Newsletter & Stay Updated
